Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis is a research paper published in EMBO Molecular Medicine (2020). On theSindex it has a DataRank of 1.6. It has been cited 45 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
0.986
From 32 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
HHS|NIH|National Heart, Lung, and Blood Institute
Grant: 1R01 HL134801
HHS|NIH|National Heart, Lung, and Blood Institute
Grant: 1R21 AG059533
U.S. Department of Defense
Grant: W81XWH‐17-1-0666
HHS|NIH|National Center for Advancing Translational Sciences
Grant: 1UG3TR002612
NHLBI NIH HHS
Grant: R01 HL127203
NHLBI NIH HHS
Grant: R01 HL134801
NCATS NIH HHS
Grant: UG3 TR002612
NIA NIH HHS
Grant: R21 AG059533
U.S. Department of Defense (DOD)
Grant: W81XWH-17-1-0666
FWCI
2.63
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals